Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II.

PLoS One · 2013 · PMC3694933 · PMID 23826206

Europe PMC DOI

hedged sentence

0.0459

closest p · 0.9× alpha

0.0459

boldest claim

The sentences

barely statistically significantp = 0.0459actually significant

The association between TGF-βRII and p-Smad2 resulted barely statistically significant (p = 0.0459): only 1 among the 9 p-Smad2 negative patients resulted positive to TGF-βRII and 10 among the 20 p-Smad2 positive resulted positive to TGF-βRII.

also in 89 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.